Lacay, Portuza A.
HRN: 11-43-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/29/2024
04/05/2024
IV
1.5gms
Q6
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes